Global Breast Cancer Drugs Market
2009-2013
Global Breast Cancer Drugs Market
Table of Contents
1. Introduction...........................................................................................................3
2. Market Size and Forecast.........................................................................................4
3. Geographic Segmentation........................................................................................5
3.1.Market Size in Americas....................................................................................6
3.2.Market Size in EMEA.........................................................................................7
3.3.Market Size in APAC..........................................................................................8
4. Market Trends in Breast Cancer Drugs.......................................................................9
5. Market Drivers in Breast Cancer Drugs....................................................................11
6. Market Challenges in Breast Cancer Drugs...............................................................12
7. Vendors...............................................................................................................14
8. Related Reports in this Series.................................................................................21
List of Exhibits
Exhibit 2.1: Breast Cancer Drugs Market Size & Forecast 2009-2013 (In $million)..............4
Exhibit 3.1: Geographic Segmentation - 2009................................................................5
Exhibit 3.2: Breast Cancer Drugs Market Size in Americas 2009-2013 (in $million).............6
Exhibit 3.3: Breast Cancer Drugs Market Size in EMEA 2009-2013 (in $million)..................7
Exhibit 3.4: Breast Cancer Drugs Market Size in APAC 2009-2013 (in $million)..................8
TechNavio Insights – Book your Analyst Hour
To become a member of TechNavio TM and enjoy the many benefits of its membership, which include
one free hour of an analyst’s time for your queries on this report, please visit:
http://www.technavio.com/user/register
2
Global Breast Cancer Drugs Market
1. Introduction
Breast Cancer Drugs are substances used to target, destroy and control the uncontrolled
growth of cells origination from breast tissue. The drugs may be used alone or in
combination with other treatments such as surgery or radiation therapy.
Every year, more than a million women are diagnosed with breast cancer, worldwide. Breast
cancer is the most common type of cancer and second leading cause of death in women,
only next to lung cancer. Though women of all ages have risk of developing breast cancer,
older woman have greater chances of developing breast cancer. The incidence rate of
breast cancer varies considerably; registering the highest rate in the North America and the
lowest rate in Africa and Asia.
The market for Breast Cancer Drugs represents an area of potential opportunity in both
developed and developing countries. As a result, a large number of companies
(pharmaceutical and biotechnology) are focusing to develop innovative breast cancer
drugs. Further, the companies are forming alliances and agreements to develop effective
treatments for breast cancer. Strategic acquisitions are also on rise to explore new markets
and strengthen R&D.
The introduction of newer cancer drugs shows promise in effective treatment of breast
cancer. The enhanced focus on tailored drug delivery in breast cancer treatment is likely to
support growth in Breast Cancer Drugs market. However, the time and high cost involved in
developing, approving a cancer drug remains a major challenge in the market.
This report highlights the scope of the Global Breast Cancer Drugs market 2009-2013,
along with trends, drivers, growth inhibitors and a few major vendors in the market.
3
Global Breast Cancer Drugs Market
2. Market Size and Forecast
According to TechNavio, the market for Global Breast Cancer Drugs is forecast to reach
$12,548.3 million in 2013 from $8,600.0 million in 2009; thus, growing at a CAGR of 9.9
percent over the period (Exhibit 2.1).
Exhibit 2.1: Breast Cancer Drugs Market Size & Forecast 2009-2013 (In $million)
14,000
12,548.3
12,000 11,369.1